News & Events

  • 24 February 2021
Rare Diseases
Background The 28 of February is International Rare Disease Day, an opportunity to raise awareness around rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. There are over 300 million people living with one or more of over 6000 identified rare diseases around the world. Although individually uncommon, there ar...
Read more
  • 09 February 2021
Webinar Series
We are back with our series of webinars which explores the way Advanced Therapeutics is driving clinicians and researchers to prepare for a new wave of therapies, revolutionising the future of paediatric health care. Register now and hear from two esteemed leaders in the field of paediatric cancer and pioneers in CAR-T cell therapy. Chimeric Antigen Receptor (CAR) T cell therapy is the most th...
Read more
  • 21 December 2020
Advanced Therapeutics
We are Australia's leaders in Paediatric Gene Therapy.  Sydney Children’s Hospitals Network (SCHN) is the largest network of hospitals and services for children in Australia. Along with our Luminesce Alliance (LA) partners, we are national leaders in diagnostic, data and disease modelling research, with the knowledge and expertise that will be required to develop, evaluate...
Read more
Grant Success
Kids Research, Sydney Children’s Hospitals Network is happy to announce that our researchers were awarded a total of more than $2.17M through the University of Sydney in the latest National Health and Medical Research Council (NHMRC) Ideas Grants round. The grants awarded will fund research into neurology, clinical nutrition and gene therapy. NHMRC’s Ideas Grant scheme aims to support innovati...
Read more
  • 01 December 2020
Webinar Series
The first in a series of educational webinars by Kids Research, Sydney Children’s Hospitals Network was held on 27 November 2020. The webinar series will explore the way Advanced Therapeutics is driving clinicians and researchers to prepare for a new wave of therapies that will revolutionise the future of paediatric health care. Watch the video of this webinar to: gain an understand...
Read more
Funding
Nine gene and cell therapy projects across the Westmead Health Precinct (Sydney Children’s Hospitals Network, Children’s Medical Research Institute (CMRI), The Westmead Institute for Medical Research (WIMR)) have been awarded funding to offer PhD scholarships for graduates to undertake research within the gene and gene-modified somatic cell therapy development and manufacture sectors by the NSW G...
Read more
  • 27 October 2020
Webinar Series
Register now for the first of a series of webinars that explores the way Advanced Therapeutics is driving clinicians and researchers to prepare for a new wave of therapies - revolutionising the future of paediatric health care. We are in a new era of paediatric medicine. Therapy that targets the underlying genetic defect causing disease is now available for a small but increasing number of dis...
Read more
Grant Success
Kids Research, Sydney Children’s Hospitals Network is delighted to announce the tremendous success of our researchers in the latest National Health and Medical Research Council (NHMRC) Investigator Grant and Medical Research Future Fund (MRFF) round. Together with University of Sydney (USYD) and University of New South Wales (UNSW), more than $13.8...
Read more
Gene Therapy
The need for effective treatments for children with rare genetic diseases has been a long and challenging road in research and the community. With the advancement of technology, research is now a step closer to an answer – gene therapy. A major game changer in medicine, gene therapy was recently addressed at the National Press Club of Australia by Dr Elizabeth Finkel, who is the first journali...
Read more
Cell and gene therapies is an exciting and emerging field with massive potential to revolutionise how we treat many diseases, particularly cancers, with many clinical trials in progress or having been completed in Australia. Moreover, recent announcements regarding reimbursement for Kymriah® CAR-T therapy for acute lymphoblastic leukaemia further highlights the promising therapeutic potential of...
Read more